Question 1

Does Corient Private Wealth own CGTX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Corient Private Wealth holds 78,226 shares of CGTX (Cognition Therapeutics), worth $89,960.

Question 2

How many shares of CGTX does Corient Private Wealth own?

Accepted Answer

As of its Q2 2026 13F, Corient Private Wealth holds 78,226 shares of CGTX (Cognition Therapeutics).

Question 3

What is Corient Private Wealth's CGTX position worth?

Accepted Answer

As of its Q2 2026 13F, Corient Private Wealth's CGTX position is worth $89,960.

Question 4

Is Corient Private Wealth buying or selling CGTX?

Accepted Answer

In Q2 2026, Corient Private Wealth increased its CGTX position by 6,114 shares (+8.5%).

Question 5

When did Corient Private Wealth first buy CGTX?

Accepted Answer

Corient Private Wealth first reported CGTX in its Q3 2025 13F and has listed it in 4 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	78,226	+8.5%	$89,960	0.0%	$1.15	23
2026-Q1	Unchanged	72,112	0.0%	$54,769	0.0%	$1.02	0
2025-Q4	Unchanged	72,112	0.0%	$97,351	0.0%	$1.37	0
2025-Q3	New	72,112	-	$97,351	0.0%	$1.43	30

CGTX4 quarters

CGTX
4 quarters